Yuan-Di Halvorsen

Technik-/Wissenschafts-/F&E-Leiter bei CINCOR PHARMA, INC.

Health Technology

Ursprung des Netzwerks ersten Grades von Yuan-Di Halvorsen

Einheit	Art der Einheit	Industrie
CINCOR PHARMA, INC. 5	Subsidiary	Pharmaceuticals: Major	5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Yuan-Di Halvorsen

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
ABIVAX	Pharmaceuticals: Other	Marc M. P. de Garidel Hema Keshava	Chief Executive Officer Corporate Officer/Principal
Tc Land Expression SA Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France.	Miscellaneous Commercial Services	Marc M. P. de Garidel	Director/Board Member
Harvard Medical School	College/University	Mason W. Freeman	Corporate Officer/Principal
Vectorlab GmbH		Marc M. P. de Garidel	Chairman
GALENICA AG	Medical Distributors	Marc M. P. de Garidel	Director/Board Member
AZTherapies, Inc. AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA.	Pharmaceuticals: Major	Marc M. P. de Garidel	Chief Executive Officer
Claris Biotherapeutics, Inc. Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ.	Pharmaceuticals: Major	Marc M. P. de Garidel	Director/Board Member
G5 Santé		Marc M. P. de Garidel	Chairman
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	College/University	Mason W. Freeman	Undergraduate Degree
CRINETICS PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Mason W. Freeman	Director/Board Member
The Innovative Medicines Initiative The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles.	Drugstore Chains	Marc M. P. de Garidel	Chairman
Mitobridge, Inc. Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA.	Biotechnology	Mason W. Freeman	Director/Board Member
University of California	College/University	Mason W. Freeman	Doctorate Degree
The General Hospital Corp. The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.	Hospital/Nursing Management	Mason W. Freeman	Corporate Officer/Principal
NOVARTIS AG	Pharmaceuticals: Major	Mason W. Freeman	Corporate Officer/Principal
SCPHARMACEUTICALS INC.	Pharmaceuticals: Major	Mason W. Freeman	Director/Board Member
5AM Venture Management LLC 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.	Investment Managers	Mason W. Freeman	Private Equity Investor
CincyTech LLC CincyTech LLC Investment ManagersFinance CincyTech LLC (CincyTech) is a venture capital firm founded in 2007. The firm is headquartered in Cincinnati, Ohio.	Investment Managers	Justin Thompson	Private Equity Analyst
University of Cincinnati (Ohio)	College/University	Justin Thompson	Graduate Degree
Corvidia Therapeutics, Inc. Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.	Biotechnology	Marc M. P. de Garidel	Chief Executive Officer
PX Therapeutics SA PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France.	Miscellaneous Commercial Services	Marc M. P. de Garidel	Director/Board Member
Suraypharm SAS		Marc M. P. de Garidel	Chairman
Leem		Marc M. P. de Garidel	Founder
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.	Pharmaceuticals: Major	Marc M. P. de Garidel	Chairman
AMGEN INC.	Pharmaceuticals: Major	Marc M. P. de Garidel	Chief Administrative Officer
European Biopharmaceutical Enterprises European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium.	Biotechnology	Marc M. P. de Garidel	Chairman
IPSEN	Pharmaceuticals: Major	Marc M. P. de Garidel	Chairman
Ecole Spéciale des Travaux Publics	College/University	Marc M. P. de Garidel	Undergraduate Degree
Thunderbird School of Global Management	College/University	Marc M. P. de Garidel	Graduate Degree
Ipsen Pharma SAS Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.	Pharmaceuticals: Major	Marc M. P. de Garidel	Chief Executive Officer
G5		Marc M. P. de Garidel	Chairman
PHARNEXT SCA	Biotechnology	Marc M. P. de Garidel	Director/Board Member
European Federation of Pharmaceutical Industries & Assns European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.	Miscellaneous Commercial Services	Marc M. P. de Garidel	Director/Board Member
ELI LILLY AND COMPANY	Pharmaceuticals: Major	Marc M. P. de Garidel	Corporate Officer/Principal
Harvard Business School	College/University	Marc M. P. de Garidel	Masters Business Admin
Société des Membres de la Légion d'Honneur		Marc M. P. de Garidel	Director/Board Member
ESSEC Business School	College/University	Marc M. P. de Garidel	Corporate Officer/Principal
ESCP Europe Campus Paris	College/University	Marc M. P. de Garidel	Corporate Officer/Principal
Washington University in St. Louis	College/University	Justin Thompson	Undergraduate Degree